TMDX241220C65000
- 2.40
- -0.85-26.15%
TransMedics Newsroom
TransMedics Stock Plunges 57.5% in Three Months: What's Next?
Express News | Transmedics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Morgan Stanley Maintains TransMedics(TMDX.US) With Hold Rating, Maintains Target Price $80
Morgan Stanley Maintains TransMedics(TMDX.US) With Hold Rating, Cuts Target Price to $80
TransMedics Group: Balancing Long-term Promise With Short-term Uncertainty – Hold Rating Maintained
Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $90
Oppenheimer Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $125
TransMedics Group Is Maintained at Overweight by Piper Sandler
A Quick Look at Today's Ratings for TransMedics(TMDX.US), With a Forecast Between $90 to $120
TransMedics Group (TMDX) Gets a Buy From Oppenheimer
Express News | Baird Maintains Outperform on TransMedics Gr, Lowers Price Target to $120
Beyond The Numbers: 13 Analysts Discuss TransMedics Gr Stock
TransMedics Price Target Lowered to $90 From $110 at Piper Sandler
Needham Reiterates Hold on TransMedics Grto Hold
TransMedics Gr Analyst Ratings
Express News | Transmedics Group Inc : Piper Sandler Cuts Target Price to $90 From $110
TransMedics Group: Promising Growth Trajectory With Strategic Expansion and Clinical Advancements
$1000 Invested In TransMedics Gr 5 Years Ago Would Be Worth This Much Today
TransMedics Sees FY25 Revenue Growth 20%-25% Over Midpoint of FY24 Guide